Trial intelligence / Profile preview

Effect of zinc sulfate in diabetic hemodialysis patients

IRCT20190806044461N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of zinc in chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM), sponsored by Zahedan University of Medical Sciences. Started Aug 2019; status: completed.

02

Drugs

zinc
03

Conditions

chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT20190806044461N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190806044461N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call